Title
Radiotherapy for single station N2 NSCLCRadiotherapy for single station N2 NSCLC
Author
Faculty/Department
Faculty of Medicine and Health Sciences
Research group
Molecular Imaging, Pathology, Radiotherapy & Oncology (MIPRO)
Publication type
article
Publication
Subject
Human medicine
Source (journal)
Translational lung cancer research. - -
Volume/pages
3(2014):4, p. 234-237
ISSN
2218-6751
Carrier
E
Target language
English (eng)
Full text (Publishers DOI)
Affiliation
University of Antwerp
Abstract
Clinical single station N2 is a prognostic factor, which is only moderately identifiable preoperatively, even after adequate mediastinal staging. There is little evidence that single station N2 predicts for the outcome of any radical treatment strategy, or for a benefit of postoperative radiotherapy. In adequately staged patients with clinical single station N2 involvement, modern definitive chemoradiation therapy results in equivalent outcome as induction therapy followed by resection.
E-info
https://repository.uantwerpen.be/docman/iruaauth/97be9d/131366.pdf
Handle